These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7797795)

  • 1. Eosinophil-active cytokine from mononuclear cells cultured with L-tryptophan products: an unexpected consequence of endotoxin contamination.
    Kita H; Mayeno AN; Weyand CM; Goronzy JJ; Weiler DA; Lundy SK; Abrams JS; Gleich GJ
    J Allergy Clin Immunol; 1995 Jun; 95(6):1261-7. PubMed ID: 7797795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of L-tryptophan products on function of human eosinophils: investigation of the causal mechanisms of eosinophilia myalgia syndrome associated with L-tryptophan products.
    Saito H; Miyamoto T
    Int Arch Allergy Immunol; 1996; 111 Suppl 1():37-42. PubMed ID: 8906111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Episodic eosinophilia-myalgia-like syndrome in a patient without L-tryptophan use: association with eosinophil activation and increased serum levels of granulocyte-macrophage colony-stimulating factor.
    Bochner BS; Friedman B; Krishnaswami G; Schleimer RP; Lichtenstein LM; Kroegel C
    J Allergy Clin Immunol; 1991 Oct; 88(4):629-36. PubMed ID: 1918729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,1'-Ethylidenebis(tryptophan) (Peak E) induces functional activation of human eosinophils and interleukin 5 production from T lymphocytes: association of eosinophilia-myalgia syndrome with a L-tryptophan contaminant.
    Yamaoka KA; Miyasaka N; Inuo G; Saito I; Kolb JP; Fujita K; Kashiwazaki S
    J Clin Immunol; 1994 Jan; 14(1):50-60. PubMed ID: 8132737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cause and pathogenesis of the eosinophilia-myalgia syndrome.
    Varga J; Uitto J; Jimenez SA
    Ann Intern Med; 1992 Jan; 116(2):140-7. PubMed ID: 1727618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-tryptophan contaminant 'peak E' induces the release of IL-5 and IL-10 by peripheral blood mononuclear cells from patients with functional somatic syndromes.
    Barth H; Klein R; Berg PA
    Clin Exp Immunol; 2001 Nov; 126(2):187-92. PubMed ID: 11703359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndrome.
    Owen WF; Petersen J; Sheff DM; Folkerth RD; Anderson RJ; Corson JM; Sheffer AL; Austen KF
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8647-51. PubMed ID: 2236076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophil-adhesion-inducing activity produced by antigen-stimulated mononuclear cells involves GM-CSF.
    Nagata M; Yamamoto H; Tabe K; Sakamoto Y; Matsuo H
    Int Arch Allergy Immunol; 2000 May; 122 Suppl 1():15-9. PubMed ID: 10867501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone inhibits prolonged survival and autocrine granulocyte-macrophage colony-stimulating factor production by human eosinophils cultured on laminin or tissue fibronectin.
    Walsh GM; Wardlaw AJ
    J Allergy Clin Immunol; 1997 Aug; 100(2):208-15. PubMed ID: 9275142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the major activity derived from cultured human peripheral blood mononuclear cells, which enhances eosinophil viability, as granulocyte macrophage colony-stimulating factor (GM-CSF).
    Burke LA; Hallsworth MP; Litchfield TM; Davidson R; Lee TH
    J Allergy Clin Immunol; 1991 Aug; 88(2):226-35. PubMed ID: 1880323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells enhance eosinophil survival in vitro: role of TNF-alpha and granulocyte-macrophage colony-stimulating factor.
    Levi-Schaffer F; Temkin V; Malamud V; Feld S; Zilberman Y
    J Immunol; 1998 Jun; 160(11):5554-62. PubMed ID: 9605160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy.
    Corrigan CJ; Hamid Q; North J; Barkans J; Moqbel R; Durham S; Gemou-Engesaeth V; Kay AB
    Am J Respir Cell Mol Biol; 1995 May; 12(5):567-78. PubMed ID: 7742019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there any relationship between eosinophilia myalgia syndrome (EMS) and fibromyalgia syndrome (FMS)? An analysis of clinical and immunological data.
    Barth H; Berg PA; Klein R
    Adv Exp Med Biol; 1999; 467():487-96. PubMed ID: 10721092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of cytokines and fibroblasts on eosinophilic granulocyte survival in polyposis nasi].
    Rudack C; Hauser U; Stoll W
    Laryngorhinootologie; 1999 Jul; 78(7):378-81. PubMed ID: 10457519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
    Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M
    Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoblastoid interferon-alpha inhibits T cell proliferation and expression of eosinophil-activating cytokines.
    Krishnaswamy G; Smith JK; Srikanth S; Chi DS; Kalbfleisch JH; Huang SK
    J Interferon Cytokine Res; 1996 Oct; 16(10):819-27. PubMed ID: 8910767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upper airway epithelial cells support eosinophil survival in vitro through production of GM-CSF and prostaglandin E2: regulation by glucocorticoids and TNF-alpha.
    Daffern PJ; Jagels MA; Saad JJ; Fischer W; Hugli TE
    Allergy Asthma Proc; 1999; 20(4):243-53. PubMed ID: 10476324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 on the secretory capacity of human blood eosinophils.
    Tai PC; Spry CJ
    Clin Exp Immunol; 1990 Jun; 80(3):426-34. PubMed ID: 2197048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive production of granulocyte/macrophage colony-stimulating factor by hypodense mononuclear eosinophils developed in vitro from hybrid eosinophil/basophil granulocytes.
    Boyce JA; Friend D; Gurish MF; Austen KF; Owen WF
    Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2436-41. PubMed ID: 8637892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of blood mononuclear cells of atopic children with the relevant allergen induces the release of eosinophil chemotaxins such as IL-3, IL-5, and GM-CSF.
    Lantero S; Sacco O; Scala C; Rossi GA
    J Asthma; 1997; 34(2):141-52. PubMed ID: 9088301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.